Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors
Authors:
- Emanuele Durante-MangoniEmanuele Durante-Mangoni
- the Monaldi Hospital Cardiovascular Infection Study GroupTGthe Monaldi Hospital Cardiovascular Infection Study Group
- 21 December 2023
- journal article
- research article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 19 (2) , 455-464
Abstract
The objective of the study was to assess the short- and long-term mortality of infective endocarditis (IE) among people who inject drugs (PWID). Using prospectively collected data on hospitalized patients (years 2000 through 2021) with IE, PWID were identified and included in this study. Survival analysis was performed to analyze short- and long-term mortality and study their risk factors among PWID and a matched group of non-intravenous drug users (N-IDU). In a study of 485 patients admitted for IE, 55 (11%) of them were PWID. These PWID patients were 1:1 age- and sex- matched to an N-IDU group (N = 55 per group). Both groups had similar baseline comorbid conditions, including congestive heart failure, type 2 diabetes, and neoplastic diseases. However, PWID were more likely to have HCV co-infection (62% vs 16%, respectively, p < 0.001) and advanced liver disease/cirrhosis (52% vs 7.9%, respectively, p < 0.001). IE in PWID more often affected the tricuspid valve (42% vs 22%, respectively, p = 0.024) and presented with more embolic events (66% vs 35%, respectively, p < 0.01). S. aureus was the primary cause of IE in PWID (44% vs 21%, respectively, p = 0.01). After adjusting for other variables, PWID (HR = 2.99, 95% CI [1.06, 8.43], p = 0.038) and valve bioprosthetic replacement (HR = 5.37, 95% CI [1.3, 22.1], p = 0.02) were independently associated with increased mortality risk, whereas IE caused by tricuspid valve infection was associated with reduced mortality risk (HR = 0.25, 95% CI [0.06, 0.97], p = 0.046). In this cohort, PWID had increased risk of long-term mortality after hospital discharge for IE, when compared to matched N-IDU with similar baseline characteristics. The reasons behind the significant increase in mortality warrant further investigation.Keywords
This publication has 36 references indexed in Scilit:
- Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis – Prospective Cohort StudyClinical Microbiology and Infection, 2014
- Infective Endocarditis Epidemiology Over Five Decades: A Systematic ReviewPLOS ONE, 2013
- Early Surgery versus Conventional Treatment for Infective EndocarditisNew England Journal of Medicine, 2012
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal InferencePolitical Analysis, 2007
- Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes from the International Collaboration on Endocarditis Merged DatabaseClinical Infectious Diseases, 2005
- Risk factors for “major” embolic events in hospitalized patients with infective endocarditisAmerican Heart Journal, 2003
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000
- Model Selection and Akaike's Information Criterion (AIC): The General Theory and its Analytical ExtensionsPsychometrika, 1987